PROPTOSIS

Clinical trials for PROPTOSIS explained in plain language.

Never miss a new study

Get alerted when new PROPTOSIS trials appear

Sign up with your email to follow new studies for PROPTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New antibody shows promise for thyroid eye disease in early trial

Disease control Completed

This study tested a new drug called LASN01 in 41 adults with moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. The drug aims to reduce eye bulging and inflammation by blocking a specific receptor. Participants received either LASN01 or a …

Matched conditions: PROPTOSIS

Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

PROPTOSIS

Get alerted when new PROPTOSIS trials appear

New antibody shows promise for thyroid eye disease in early trial